May 22, 2025 07:11AM
May 22, 2025 07:10AM
Jan 14, 2025 07:30AM
Jan 14, 2025 07:30AM
May 28, 2024 08:05AM
May 2, 2024 05:24AM
Jan 30, 2024 09:15AM Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
Dec 5, 2023 08:00AM
Jul 27, 2023 07:02AM
Jul 27, 2023 07:00AM
Jun 15, 2023 04:49PM
Jun 15, 2023 04:45PM
Jun 5, 2023 07:01AM
Jun 5, 2023 07:00AM NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
May 30, 2023 07:00AM
Apr 24, 2023 07:00AM
Apr 6, 2023 07:00AM
Mar 16, 2023 07:00AM
Feb 6, 2023 07:00AM
Nov 21, 2022 07:02AM
Nov 21, 2022 07:00AM RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease
Nov 18, 2022 09:22AM
Nov 18, 2022 09:20AM
Oct 28, 2022 07:00AM
Sep 7, 2022 02:44AM
Sep 7, 2022 02:00AM
Jun 24, 2022 09:00PM
Jun 21, 2022 02:00AM NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
May 10, 2022 05:32AM
May 10, 2022 02:00AM
May 9, 2022 07:00AM
Apr 25, 2022 07:06AM
Apr 25, 2022 07:00AM
Apr 11, 2022 10:02AM
Apr 11, 2022 10:00AM NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
Mar 28, 2022 04:11PM
Mar 28, 2022 04:05PM
Mar 17, 2022 03:00AM
Feb 14, 2022 07:00AM
Feb 11, 2022 02:00AM
Jan 11, 2022 07:00AM
Dec 13, 2021 04:49AM NeoGenomics' (NEO) Inivata Appoints David Eberhard as Chief Medical Officer
Dec 13, 2021 02:00AM
Oct 19, 2021 02:00AM
Oct 1, 2021 09:27AM
Sep 9, 2021 07:00AM
May 12, 2021 04:05PM
May 5, 2021 12:00AM
Mar 24, 2021 07:02AM NeoGenomics (NEO) to Acquire Trapelo Health
Mar 24, 2021 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All